Digital program to help quit tobacco use
Official title: Cessation Clinical Trial
Run by Truth Initiative · NCT06806098 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study tests whether a digital program can help people quit using tobacco better than regular support methods.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2220 (estimated) |
| Sponsor | Truth Initiative Academic / other |
| Locations | 1 site (Washington, District of Columbia) |
| Trial ID | NCT06806098 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are current tobacco users residing in the US who have access to an active text message plan.
✕Probably not a fit
Patients aged 25 or older will not be eligible for this study and may not benefit from its findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of a digital cessation program developed by the Truth Initiative in promoting abstinence from tobacco products compared to standard care. Participants will be enrolled based on their current tobacco use and will receive either the digital intervention or usual care. The study aims to assess how well the digital program helps users quit smoking and other tobacco products over a specified period.
Why it matters
Potential benefit: If successful, this program could significantly improve the rates of tobacco cessation among users.
How similar studies have gone: Other studies have shown success with digital interventions for tobacco cessation, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current tobacco use (past 30-day use of one or more of the following: cigarettes, cigars, little cigars, cigarillos, e-cigarettes, or oral nicotine products) * US residence * Active text message plan (phase 2 only) Exclusion Criteria: * Age 25 or above (phase 2 only)
Where it's running
-
Truth Initiative
Washington, District of Columbia, United States Recruiting
Study contacts
- Study coordinator: Managing Director, Research
- Email: cessation_research@truthinitiative.org
- Phone: 202-525-6473
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Automating Tobacco Cessation in Primary Care
This project tests a workflow in primary care to identify smokers and help them access nicotine replacement therapy (NRT) during routine visits.
-
Text2Quit-Kenya: a mobile message program to help ED patients quit tobacco
Researchers will test a text message-based smoking-cessation program with Kenyan emergency department patients to see if it helps people quit and learn what works in this setting.
-
Extended tobacco support for people experiencing homelessness
This program tests whether extending tobacco treatment to 6 months with pharmacist counseling, monthly nicotine replacement deliveries, and phone wellness coaching helps adults experiencing homelessness quit smoking compared with a 3-month package.
-
Trauma-informed smoking cessation support during pregnancy
This project will test a trauma-informed smoking cessation program that combines the 4Rs with the 5As to help pregnant women who smoke and have histories of trauma.
-
Treatment for quitting cigarettes and reducing cannabis use
This study tests if a medication called varenicline can help adults who smoke cigarettes and use cannabis quit smoking and cut down on cannabis use, with support from counseling and online resources.
-
Improving tobacco cessation support for patients in poverty in Utah
This study is testing new ways to help people living in poverty in Utah quit smoking by using support tools and strategies in their healthcare clinics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.